Maximus, Inc. (NYSE:MMS) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. decreased its position in Maximus, Inc. (NYSE:MMS - Free Report) by 45.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 129,385 shares of the health services provider's stock after selling 106,921 shares during the period. Ameriprise Financial Inc. owned about 0.23% of Maximus worth $9,659,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Algert Global LLC grew its holdings in Maximus by 12.1% during the 4th quarter. Algert Global LLC now owns 187,017 shares of the health services provider's stock valued at $13,961,000 after buying an additional 20,215 shares during the last quarter. Freestone Grove Partners LP purchased a new position in Maximus in the 4th quarter valued at about $1,718,000. AQR Capital Management LLC grew its holdings in shares of Maximus by 189.1% during the fourth quarter. AQR Capital Management LLC now owns 423,298 shares of the health services provider's stock worth $31,599,000 after buying an additional 276,859 shares in the last quarter. Northern Trust Corp increased its stake in shares of Maximus by 13.2% during the 4th quarter. Northern Trust Corp now owns 815,133 shares of the health services provider's stock valued at $60,850,000 after acquiring an additional 94,858 shares during the last quarter. Finally, Aquatic Capital Management LLC increased its holdings in shares of Maximus by 128.8% during the 4th quarter. Aquatic Capital Management LLC now owns 15,328 shares of the health services provider's stock worth $1,144,000 after buying an additional 8,628 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity

In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company's stock.

Maximus Stock Down 1.8%

Shares of NYSE:MMS traded down $1.33 during midday trading on Friday, hitting $72.36. 456,402 shares of the company's stock traded hands, compared to its average volume of 562,495. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company has a market cap of $4.08 billion, a PE ratio of 15.56 and a beta of 0.61. The firm's fifty day moving average price is $69.37 and its two-hundred day moving average price is $72.05. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The company's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.57 earnings per share. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.66%. Maximus's payout ratio is currently 23.86%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.